epicardio_admin

About epicardio_admin

https://www.epicard.io

Posts by Vassilios Hurmusiadis:

Epicardio exceeds 10k users in 2023

epicardio_user_map_2023_apps
epicardio_user_data_2023
Epicardio Simulation™ was used by more than 10,000 individual users from around the world in 2023.

Epicardio on the Medtronic Academy

vEPG_on_MA
IMG_0018
IMG_0021

Great news for temporary pacing education!

Our 3D interactive simulator, Epicardio Simulation™, will now be included as part of VirtualEPG, a cutting-edge interactive cross-platform training course for cardiac surgeons to learn about the latest technology for single- and dual-chamber temporary external pacemakers anytime, anywhere.

It integrates 3D simulation of the heart providing live views of human cardiac electrophysiology and interactivity with the digital version of the device, followed by clear instruction and knowledge check, which enables active training-by-doing.

The VirtualEPG training course will be available on the Medtronic Academy, a medical education digital platform run by the leading healthcare technology company, Medtronic, as part of its commitment to training surgeons and healthcare professionals.

We are proud to contribute to creating a seamless, collaborative approach to temporary pacemaker training.

Epicardio at AU 2023

AU_EPI
IMG_7
IMG_8
Epicardio participated in a round table discussion on Digital Health with Dr Vassilios Hurmusiadis

Epicardio at ESC 2023

ESC23_EPI_AFIB
IMG_1273
IMG_1293
Epicardio presented abstract “Real-time Interactive 3d Simulation of Atrial Fibrillation for Education” with Dr Malcolm Finlay, and exhibited the latest Epicardio Simulation™ series with SCHILLER AG

Epicardio at HRS 2023

IMG_0772
IMG_0773
IMG_0774

Epicardio attended HRS 2023 in New Orleans.

Epicardio signs agreement with CHART Healthcare Academy

CHART-EPicardio_Post-LI
CHART-EPicardio_Post-2_LI

Epicardio signed a collaboration and reseller agreement with CHART Healthcare Academy in the USA

Epicardio doubles its global presence in 2022

epicardio_user_map_2022
epicardio_user_graphs_2022

Epicardio Simulation™ is celebrating more than 6,000 individual users from around the world in 2022. A total of 72,324 hours were spent on Epicardio apps, with more that 18 hours of total average daily usage. Overall Epicardio usage more than doubled since 2021.

Epicardio wins Innovate UK’s Global Cooperation grant

Epicardio wins prestigious Global Cooperation grant award by Innovate UK, aiming to facilitate Epicardio’s entry into the North American medical education market. As part of this project we will start trials at leading medical schools in USA, Canada and Mexico.

Innovate UK, the UK’s innovation agency, drives productivity and economic growth by supporting businesses to develop and realise the potential of new ideas. Innovate UK is part of UK Research and Innovation

Load More

Loading...